MedWatch

Fertin Pharma acquires two companies and bets on cannabis: "It has a great future"

Danish company Fertin Pharma plans to start production of cannabis chewing gum and enters the recently liberalized Canadian cannabis market by acquiring two other firms.

Foto: Ritzau Scanpix/Sebastian Buur Gunvald

Fertin Pharma expands focus and establishes a new business with one of the most debated drugs of our time: cannabis.

The Danish nicotine gum company thus acquired two other companies - Danish medical cannabis firm Medcan and Canadian Tab Labs that produces chewing gums and mint tablets for the North American market.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier